Literature DB >> 25919268

Frequency and risk factors of blood transfusion in abdominoplasty in post-bariatric surgery patients: data from the nationwide inpatient sample.

Hossein Masoomi1, Jonathan Rimler, Garrett A Wirth, Christine Lee, Keyianoosh Z Paydar, Gregory R D Evans.   

Abstract

BACKGROUND: There are limited data regarding blood transfusion following abdominoplasty, especially in post-bariatric surgery patients. The purpose of this study was to evaluate (1) the frequency and outcomes of blood transfusion in post-bariatric surgery patients undergoing abdominoplasty and (2) the predictive risk factors of blood transfusion in this patient population.
METHODS: Using the Nationwide Inpatient Sample database, the authors examined the clinical data of patients with a history of bariatric surgery who underwent abdominoplasty from 2007 to 2011 in the United States.
RESULTS: A total of 20,130 post-bariatric surgery patients underwent abdominoplasty during this period. Overall, 1871 patients (9.3 percent) received blood transfusion. Chronic anemia patients had the highest rate of blood transfusion (25.6 percent). Post-bariatric surgery patients who received blood transfusion experienced a significantly higher complication rate (10.1 percent versus 4.8 percent; p < 0.01), longer mean hospital stay (4.0 days versus 2.4 days; p < 0.01), and higher mean total hospital charges ($49,116 versus $33,927; p < 0.01). Multivariate regression analysis showed that deficiency anemia (adjusted OR, 3.8), congestive heart failure (adjusted OR, 2.4), concurrent breast reduction (adjusted OR, 1.5), diabetes mellitus (adjusted OR, 1.4), coronary artery disease (adjusted OR, 1.4), African American race (adjusted OR, 1.4), Hispanic race (adjusted OR, 1.4), and female sex (adjusted OR, 1.3) were all independent risk factors for blood transfusion.
CONCLUSIONS: The blood transfusion rate in post-bariatric surgery abdominoplasty patients is not insignificant. Chronic anemia and congestive heart failure are the two major predictors of transfusion. Modifying risk factors such as anemia before abdominoplasty might significantly decrease the possibility of blood transfusion. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Year:  2015        PMID: 25919268     DOI: 10.1097/PRS.0000000000001161

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Postoperative Ketorolac in Breast and Body Contouring Procedures: A Nationwide Claims Analysis.

Authors:  Brian P Kelley; Kevin C Chung; Ting-Ting Chung; Katelyn G Bennett; Gina Sacks; Erika D Sears; Jennifer F Waljee
Journal:  Plast Reconstr Surg       Date:  2018-10       Impact factor: 4.730

2.  What Is the Impact of Comorbidities on the Risk for Postoperative Body-Contouring Surgery Complications in Postbariatric Patients?

Authors:  Simone Corrêa Rosa; Jefferson Lessa Soares de Macedo; Lucas Ribeiro Canedo; Luiz Augusto Casulari
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

3.  Abdominoplasty in the Massive Weight Loss Patient: Are Aesthetic Goals and Safety Mutually Exclusive?

Authors:  Richard J Restifo
Journal:  Aesthet Surg J Open Forum       Date:  2021-04-05

4.  Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.

Authors:  Juan Carlos Montano-Pedroso; Elvio Bueno Garcia; Neil Ferreira Novo; Daniela Francescato Veiga; Lydia Masako Ferreira
Journal:  Trials       Date:  2016-04-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.